Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
Terray Therapeutics’ $120 Million Series B Funding
Terray Therapeutics’ $60 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Terray Therapeutics on the deal. Terray Therapeutics, an AI-powered drug discovery company, announced the closing of a $60 million Series...